Meta-Analysis
Copyright ©The Author(s) 2023.
World J Diabetes. Aug 15, 2023; 14(8): 1289-1300
Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1289
Figure 1
Figure 1 PRISMA summarizing the trial flow.
Figure 2
Figure 2 Results of the risk of bias in non-randomized studies of interventions tool for the extracted articles.
Figure 3
Figure 3 Forest plots and meta-analyses results. A: The occurrence of death after any hepatocellular carcinoma (HCC) treatment and only after curative therapies: Metformin vs no metformin in type 2 diabetes mellitus (T2DM) patients; B: The occurrence of progressive tumor disease and HCC recurrence after any HCC treatment: Metformin vs no metformin in T2DM patients. HCC: Hepatocellular carcinoma.
Figure 4
Figure 4 Funnel plot of the studies selected in the present meta-analysis.